3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide

C26H25FN8O — CID 154060343

IUPAC3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide
SMILESCN1CCN(c2ccc(Nc3ncc4cccc(-c5cc(NC(=O)C=CF)ccn5)c4n3)cn2)CC1
InChIInChI=1S/C26H25FN8O/c1-34-11-13-35(14-12-34)23-6-5-20(17-29-23)32-26-30-16-18-3-2-4-21(25(18)33-26)22-15-19(8-10-28-22)31-24(36)7-9-27/h2-10,15-17H,11-14H2,1H3,(H,28,31,36)(H,30,32,33)
InChIKeyIAHHBYIHXIDMLV-UHFFFAOYSA-N
MW484.54 g/mol
LogP4.00
Rot. Bonds6

About 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide

3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide (PubChem CID 154060343) has the molecular formula C26H25FN8O and a molecular weight of 484.54 g/mol. Its IUPAC name is 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide.

Molecular Properties

Compound Name3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide
PubChem CID154060343
Molecular FormulaC26H25FN8O
Molecular Weight484.54 g/mol
Exact Mass484.21
IUPAC Name3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide
SMILESCN1CCN(c2ccc(Nc3ncc4cccc(-c5cc(NC(=O)C=CF)ccn5)c4n3)cn2)CC1
InChIInChI=1S/C26H25FN8O/c1-34-11-13-35(14-12-34)23-6-5-20(17-29-23)32-26-30-16-18-3-2-4-21(25(18)33-26)22-15-19(8-10-28-22)31-24(36)7-9-27/h2-10,15-17H,11-14H2,1H3,(H,28,31,36)(H,30,32,33)
InChIKeyIAHHBYIHXIDMLV-UHFFFAOYSA-N
XLogP4.00
TPSA99.17 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500484.54
LogP ≤ 54.00
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide?
The IUPAC name of 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide (CID 154060343) is 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide.
What is the SMILES notation for 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide?
The canonical SMILES for 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide is CN1CCN(c2ccc(Nc3ncc4cccc(-c5cc(NC(=O)C=CF)ccn5)c4n3)cn2)CC1.
What is the InChIKey of 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide?
The InChIKey is IAHHBYIHXIDMLV-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H25FN8O/c1-34-11-13-35(14-12-34)23-6-5-20(17-29-23)32-26-30-16-18-3-2-4-21(25(18)33-26)22-15-19(8-10-28-22)31-24(36)7-9-27/h2-10,15-17H,11-14H2,1H3,(H,28,31,36)(H,30,32,33).
What are the key properties of 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide?
3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide has a molecular weight of 484.54 g/mol, XLogP of 4.00, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-fluoro-N-[2-[2-[[6-(4-methylpiperazin-1-yl)-3-pyridinyl]amino]quinazolin-8-yl]-4-pyridinyl]prop-2-enamide is sourced from PubChem (CID 154060343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).